Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Subcision + CaHA vs Subcision + CROSS TCA for Atrophic Acne Scars
NCT07028567Completed
- Sponsor
- Tanta University
- Start
- Jan 2023
- Primary completion
- Jun 2023
- Modality
- Device-based Delivery
- Countries
- 1
01
Overview
Open-label, single-arm trial of calcium hydroxyapatite in atrophic acne scar, sponsored by Tanta University. Primary endpoint: Patient satisfaction at 1 week. Started Jan 2023; status: completed.
02
Drugs
calcium hydroxyapatite
03
Conditions
atrophic acne scar
Beyond the preview
Go deeper on NCT07028567.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07028567.